Rubella Clinical Trials

• Rubella Susceptibility in Multiparous Women
  ClinicalTrials.gov Identifier: NCT00401505 - Recruiting
  Rubella; Vaccine
  
• Study to Evaluate Frozen versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine
  ClinicalTrials.gov Identifier: NCT00092430 - Active, not recruiting
  Measles; Mumps; Rubella; Varicella
  
• ProQuad™ Concomitant Use Study with Prevnar™ and IPOL™
  ClinicalTrials.gov Identifier: NCT00109343 - Active, not recruiting
  Measles; Mumps; Rubella; Varicella
  
• Long-Term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined Vaccine
  ClinicalTrials.gov Identifier: NCT00406211 - Active, not recruiting
  Measles; Mumps; Rubella; Varicella
  
• Immunogenicity, Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™
  ClinicalTrials.gov Identifier: NCT00353288 - Active, not recruiting
  Measles; Mumps; Rubella; Varicella
  
• Immunogenicity/Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA): Using Two Different Administration Routes
  ClinicalTrials.gov Identifier: NCT00351923 - Active, not recruiting
  Measles; Mumps; Rubella; Varicella
  
• Evaluation of a Combined Vaccine Against 4 Viral Childhood Diseases: Measles, Mumps, Rubella and Chickenpox.
  ClinicalTrials.gov Identifier: NCT00226499 - Active, not recruiting
  Measles; Mumps; Rubella; Chickenpox
  
• A Study of An Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age
  ClinicalTrials.gov Identifier: NCT00092391 - Active, not recruiting
  Measles; Mumps; Rubella; Varicella
  
• Safety, Tolerability, and Immunogenicity of an Investigational Vaccine with Recombinant Human Albumin (rHA) in Children 12 to 18 Months of Age
  ClinicalTrials.gov Identifier: NCT00092404 - Active, not recruiting
  Measles; Mumps; Rubella; Varicella
  
• A Measles, Mumps, and Rubella Investigational Vaccine Trial
  ClinicalTrials.gov Identifier: NCT00109278 - Active, not recruiting
  Measles
  
• Immunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined Vaccine
  ClinicalTrials.gov Identifier: NCT00313950 - Recruiting
  Measles; Mumps; Rubella; Hepatitis A
  
• Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases
  ClinicalTrials.gov Identifier: NCT00127010 - Completed
  Measles; Mumps; Rubella; Chickenpox
  
• Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases
  ClinicalTrials.gov Identifier: NCT00126997 - Completed
  Measles; Mumps; Rubella; Chickenpox
  
• Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases
  ClinicalTrials.gov Identifier: NCT00127023 - Completed
  Measles; Mumps; Rubella; Chickenpox
  
• A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers
  ClinicalTrials.gov Identifier: NCT00384397 - Active, not recruiting
  Meningococcal Meningitis; Measles; Mumps; Rubella; Varicella
  
• ProQuad® rHA Safety
  ClinicalTrials.gov Identifier: NCT00560755 - Recruiting
  Measles; Mumps; Rubella; Varicella
  
• Safety & Immunogenicity Study of Meningococcal Vaccine GSK134612 Given With Priorix-Tetra™ to 12-23 Month-Old Children.
  ClinicalTrials.gov Identifier: NCT00474266 - Active, not recruiting
  Meningococcal Serogroups A, C, W-135 and/or Y Disease; Measles; Mumps; Rubella; Varicella
  
• Concomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella, and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month Old Children
  ClinicalTrials.gov Identifier: NCT00312858 - Active, not recruiting
  Hepatitis A
  
• Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (FluMist) and Measles, Mumps, Rubella, and Varicella Vaccines Administered Concurrently to Healthy Children
  ClinicalTrials.gov Identifier: NCT00192491 - Active, not recruiting
  Influenza
  
• Comparative Study of Immunogenicity and Safety of a 2-Dose Regimen of ProQuad® Manufactured With rHA
  ClinicalTrials.gov Identifier: NCT00566527 - Recruiting
  Measles; Mumps; Rubella; Varicella
  
• Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy Toddlers.
  ClinicalTrials.gov Identifier: NCT00422292 - Recruiting
  Meningococcal Meningitis; Measles; Mumps; Rubella; Varicella
  
• Study of the Safety of Menactra® Vaccine When Administered With Other Pediatric Vaccines to Healthy Toddlers
  ClinicalTrials.gov Identifier: NCT00483574 - Recruiting
  Meningococcal Meningitis; Measles; Mumps; Rubella; Varicella
  
• Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly
  ClinicalTrials.gov Identifier: NCT00432042 - Recruiting
  Varicella; Measles; Mumps; Rubella; Diphtheria; Tetanus; Pertussis; Poliomyelitis; Hepatitis B; Haemophilus Infections
  
• Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age
  ClinicalTrials.gov Identifier: NCT00578175 - Recruiting
  Diseases Caused by Measles, Mumps, Rubella and Varicella Viruses
  
• Immunogenicity, Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™
  ClinicalTrials.gov Identifier: NCT00352898 - Completed
  Measles; Mumps; Rubella; Varicella
  
• MMR and Varicella Vaccine in Premature Infants
  ClinicalTrials.gov Identifier: NCT00156559 - Completed
  Chickenpox; Rubella; Rubeola; Mumps
  
• Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella [Oka/Merck] Virus Vaccine Live Safety Study
  ClinicalTrials.gov Identifier: NCT00326183 - Completed
  Hepatitis A; Measles; Mumps; Rubella; Chickenpox
  
• Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Measles/Mumps/Rubella Vaccine & a Varicella (Chickenpox) Vaccine in Healthy Children
  ClinicalTrials.gov Identifier: NCT00197015 - Recruiting
  Hepatitis A
  
• A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group
  ClinicalTrials.gov Identifier: NCT00000815 - Active, not recruiting
  HIV Infections; Measles
  
• Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00013871 - Active, not recruiting
  HIV Infections; Hepatitis B; Measles; Pneumococcal Infections; Pertussis
  
• ProQuad® Intramuscular vs Subcutaneous
  ClinicalTrials.gov Identifier: NCT00402831 - Completed
  Measles; Mumps; Rubella; Varicella
  
• Responses of Premature Infants to MMR & Varicella Vaccines
  ClinicalTrials.gov Identifier: NCT00138255 - Terminated
  Measles; Mumps; Rubella; Varicella
  
• Safety Study of a Refrigerator-Stable Formulation of VARIVAX®
  ClinicalTrials.gov Identifier: NCT00432731 - Completed
  Varicella; Measles; Mumps; Rubella
  
• Assess GSK Biologicals' MMR Vaccine (Priorix) When Given to Healthy Children at the Age of 12 to 18 Months in Singapore.
  ClinicalTrials.gov Identifier: NCT00388440 - Completed
  Measles; Mumps; Rubella
  
• Trial to Assess Safety, Efficacy, Tolerability and Immunogenicity of Influenza Virus Vaccine, Liquid Formulation (CAIV-T), Administered Concomitantly With a Combination Live, Attenuated, Mumps, Measles, and Rubella Vaccine in Healthy Children Aged 11 –
  ClinicalTrials.gov Identifier: NCT00192166 - Completed
  Influenza
  
• Immune Responses to Two Dose Varivax +/- MMR-II
  ClinicalTrials.gov Identifier: NCT00258726 - Terminated
  Measles; Mumps; Rubella; Varicella